Lazard Asset Management LLC Eton Pharmaceuticals, Inc. Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,031 shares of ETON stock, worth $16,929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,031Holding current value
$16,929% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ETON
# of Institutions
72Shares Held
12.2MCall Options Held
259KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.85MShares$46.8 Million7.38% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.83MShares$30 Million1.12% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.12MShares$18.4 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$17.5 Million0.0% of portfolio
-
Westside Investment Management, Inc.575KShares$9.45 Million1.61% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $415M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...